Last reviewed · How we verify
Assessment of Rituximab Efficiency and Tolerance in Treatment of Bullous Pemphigoid. (Rituximab2)
The aim of the study is to assess that it will be possible to control with a single cycle of rituximab patient with bullous pemphigoid.
Details
| Lead sponsor | University Hospital, Rouen |
|---|---|
| Phase | Phase 3 |
| Status | COMPLETED |
| Enrolment | 18 |
| Start date | 2008-12 |
| Completion | 2013-12 |
Conditions
- Bullous Pemphigoid
Interventions
- Mabthera
Primary outcomes
- Clinical and biological controls of bullous pemphigoid were estimated every seven days during a period of 1 month and every month during a period of 2 years. — 2 years
Countries
France